vaccinetracker.ecdc.europa.eu Open in urlscan Pro
88.131.255.91  Public Scan

Submitted URL: http://88.131.255.91/
Effective URL: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html
Submission: On November 22 via manual from PT — Scanned from DE

Form analysis 3 forms found in the DOM

<form id="dataExportForm" class="ng-pristine ng-valid">
  <div class="modal-body">
    <div class="form-group row">
      <label for="dataFormat" class="col-sm-3 col-form-label">Format</label>
      <div id="dataFormat" class="col-sm-9 btn-group" role="group">
        <button id="dataFormatCsv" type="button" class="qcmd btn btn-outline-covid-primary active">CSV</button>
        <button id="dataFormatXml" type="button" class="qcmd btn btn-outline-covid-primary">XML</button>
        <button id="dataFormatJson" type="button" class="qcmd btn btn-outline-covid-primary">JSON</button>
      </div>
    </div>
  </div>
  <div class="modal-footer">
    <button class="qcmd btn btn-covid-secondary" data-dismiss="modal">Close</button>
    <button class="qcmd btn btn-covid-primary" type="submit">Export</button>
  </div>
</form>

<form id="bookmarkForm" class="ng-pristine ng-valid">
  <div class="modal-body">
    <div class="form-group row">
      <label for="bmtitle" class="col-sm-3 col-form-label">Title</label>
      <div class="col-sm-9"><input type="text" id="bmtitle" class="qcmd form-control" required=""></div>
    </div>
    <div class="form-group row">
      <label for="bmdesc" class="col-sm-3 col-form-label">Description</label>
      <div class="col-sm-9"><input type="text" id="bmdesc" class="qcmd form-control"></div>
    </div>
  </div>
  <div class="modal-footer">
    <button class="qcmd btn btn-covid-secondary" data-dismiss="modal">Close</button>
    <button class="qcmd btn btn-covid-primary" type="submit">Create</button>
  </div>
</form>

<form id="exportForm" class="ng-pristine ng-valid">
  <div class="modal-body">
    <div id="exportType" class="form-group">
      <div class="form-check">
        <input class="form-check-input" type="radio" name="exportType" id="exportData" value="data" checked="">
        <label class="form-check-label" for="exportData">Export data</label>
      </div>
      <div class="form-check">
        <input class="form-check-input" type="radio" name="exportType" id="exportImg" value="img">
        <label class="form-check-label" for="exportImg">Export as an image</label>
      </div>
      <!--
							<div class="form-check">
								<input class="form-check-input" type="radio" name="exportType" id="exportPdf" value="pdf">
								<label class="form-check-label" for="exportPdf">Export to pdf</label>
							</div>
							-->
    </div>
    <div id="exportImgSettings" class="form-group hidden">
      <div class="form-group row" style="display:none">
        <label for="imgSize" class="col-sm-3 col-form-label">Image size</label>
        <div id="imgSize" class="col-sm-9 btn-group" role="group">
          <button id="imgSizeCurrent" type="button" class="qcmd btn btn-outline-covid-primary active">Default</button>
          <button id="imgSizeCustom" type="button" class="qcmd btn btn-outline-covid-primary">Custom</button>
        </div>
      </div>
      <div class="form-group row">
        <label for="imgSizeWidth" class="col-sm-3 col-form-label">Width (pixels)</label>
        <div class="col-sm-9"><input type="number" min="0" id="imgSizeWidth" class="qcmd form-control"></div>
      </div>
      <div class="form-group row">
        <label for="imgSizeHeight" class="col-sm-3 col-form-label">Height (pixels)</label>
        <div class="col-sm-9"><input type="number" min="0" id="imgSizeHeight" class="qcmd form-control"></div>
      </div>
      <div class="form-group row">
        <label for="imgTypeSelect" class="col-sm-3 col-form-label">File type</label>
        <div class="col-sm-9"><select id="imgTypeSelect" class="qcmd form-control">
            <option value="PNG" selected="">Png</option>
            <option value="JPG">Jpeg</option>
          </select></div>
      </div>
    </div>
    <div id="exportPdfSettings" class="form-group hidden">
      <div class="form-group row">
        <label for="paperSizeSelect" class="col-sm-3 col-form-label">Paper size</label>
        <div class="col-sm-9"><select id="paperSizeSelect" class="qcmd form-control">
            <option value="A3">A3</option>
            <option value="A4" selected="">A4</option>
            <option value="A5">A5</option>
            <option value="A6">A6</option>
            <option value="A7">A7</option>
            <option value="custom">Custom</option>
          </select></div>
      </div>
      <div class="form-group row">
        <label for="paperSizeWidth" class="col-sm-3 col-form-label">Width (mm)</label>
        <div class="col-sm-9"><input type="number" min="0" id="paperSizeWidth" class="qcmd form-control" disabled=""></div>
      </div>
      <div class="form-group row">
        <label for="paperSizeHeight" class="col-sm-3 col-form-label">Height (mm)</label>
        <div class="col-sm-9"><input type="number" min="0" id="paperSizeHeight" class="qcmd form-control" disabled=""></div>
      </div>
      <div class="form-group row">
        <label for="pdfOrientation" class="col-sm-3 col-form-label">Orientation</label>
        <div id="pdfOrientation" class="col-sm-9 btn-group" role="group">
          <button id="pdfOrientationPortrait" type="button" class="qcmd btn btn-outline-covid-primary">Portrait</button>
          <button id="pdfOrientationLandscape" type="button" class="qcmd btn btn-outline-covid-primary active">Landscape</button>
        </div>
      </div>
      <div class="form-group row">
        <label for="pdfAspectRatio" class="col-sm-3 col-form-label">Aspect ratio</label>
        <div id="pdfAspectRatio" class="col-sm-9 btn-group" role="group">
          <button id="pdfAspectRatioCurrent" type="button" class="qcmd btn btn-outline-covid-primary">Default size</button>
          <!--button id="pdfAspectRatioCustom" type="button" class="qcmd btn btn-outline-covid-primary">Custom size</button-->
          <button id="pdfAspectRatioFitPage" type="button" class="qcmd btn btn-outline-covid-primary active">Fit to page</button>
        </div>
      </div>
      <div class="form-group row hidden">
        <label for="objSizeWidth" class="col-sm-3 col-form-label">Width (pixels)</label>
        <div class="col-sm-9"><input type="number" min="0" id="objSizeWidth" class="qcmd form-control" disabled=""></div>
      </div>
      <div class="form-group row hidden">
        <label for="objSizeHeight" class="col-sm-3 col-form-label">Height (pixels)</label>
        <div class="col-sm-9"><input type="number" min="0" id="objSizeHeight" class="qcmd form-control" disabled=""></div>
      </div>
    </div>
  </div>
  <div class="modal-footer">
    <button class="qcmd btn btn-covid-secondary" data-dismiss="modal">Close</button>
    <button class="qcmd btn btn-covid-primary" type="submit">Export</button>
  </div>
</form>

Text Content

Manage cookies


COOKIES

We use cookies to collect statistics on how the visitors navigate the website
and to improve the user experience. Find out more on how we use cookies and how
you can change your settings.

I accept cookies
I don't accept cookies
Remind me later


EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL

COVID-19 VACCINE TRACKER

   
 * Reset selections
 * Help
 * Mobile version

Open data Vaccine Tracker Weekly country overviews ECDC-WHO COVID-19 Explorer
 *  

 * Key Figures
 * Vaccine Uptake
   
 * Age Groups
 * Doses by Product
 * Country Profiles
 * Notes on the data
 * Help

Disclaimer: the information presented in the ECDC Vaccine Tracker is based on
data reported by EU/EEA countries to the European Surveillance System (TESSy).
EU/EEA countries are requested to report data every two weeks on Tuesdays. The
data in the tracker are refreshed every two weeks on Thursdays at 11h after
validation at ECDC level. Considering this reporting timeframe and the time ECDC
needs to process the data, some discrepancies may be observed between the
figures published by ECDC and the ones presented in official national reports or
web sites. Users are advised to use all data with caution and be aware of their
limitations. Data for the current week are preliminary, as countries may be
uploading only partial data. All data are subject to retrospective corrections;
corrected datasets are released as soon as processing of updated national data
has been completed. Please refer to the "Notes on the data" tab for additional
information.
Key figures of the COVID-19 vaccine rollout
Country:

Reporting Week:


Country figures
EU EU/EEA


NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS

This refers to the total cumulative number of doses of any vaccine product
distributed by manufacturers to EU/EEA countries.


NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES PER
HUNDRED INHABITANTS

This refers to the total number of vaccine doses distributed by manufacturers to
EU/EEA countries divided by the size of the total population in each country.
Population denominators for the total population are obtained from Eurostat/UN.


NUMBER OF VACCINE DOSES ADMINISTERED

This refers to the total number of doses of any vaccine product administered in
EU/EEA countries.


CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of a complete primary course with any
vaccine product and is presented for the total population, adults (18+), people
aged 60 years and above (60+) and children below 18 years. It is calculated as
follows: number of complete primary courses administered divided by the size of
the population. The uptake is expressed as percentage (%). Primary course is
defined according to the authorised schedule for each vaccine product at EU
level. Population denominators are obtained from Eurostat/UN.


CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the first booster dose and is presented
for the total population, adults (18+) and people aged 60 years and above (60+).
See definition of first booster below. It is calculated as follows: number of
first booster doses cumulatively administered divided by the size of the
population. The uptake is expressed as percentage (%). Population denominators
are obtained from Eurostat/UN.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.


CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the second booster dose and is presented
for the total population, adults (18+) and people aged 60 years and above (60+).
See definition of second booster below. It is calculated as follows: number of
second booster doses cumulatively administered divided by the size of the
population. The uptake is expressed as percentage (%). Population denominators
are obtained from Eurostat/UN.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.


NUMBER OF VACCINE DOSES ADMINISTERED

This refers to the total number of doses of any vaccine product administered in
EU/EEA countries.


CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of at least one vaccine dose of any vaccine
product and is presented for the total population and adults (18+). It is
calculated as follows: number of first doses cumulatively administered divided
by the size of the population The uptake is expressed as percentage (%).
Population denominators are obtained from Eurostat/UN.


CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of a complete primary course with any
vaccine product and is presented for the total population and adults (18+). It
is calculated as follows: number of complete primary courses administered
divided by the size of the population. The uptake is expressed as percentage
(%). Primary course is defined according to the authorised schedule for each
vaccine product at EU level. Population denominators are obtained from
Eurostat/UN.


CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the first booster dose and is presented
for the total population and adults (18+). See definition of first booster
below. It is calculated as follows: number of first booster doses cumulatively
administered divided by the size of the population. The uptake is expressed as
percentage (%). Population denominators are obtained from Eurostat/UN.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.


CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the second booster dose and is presented
for the total population and adults (18+). See definition of second booster
below. It is calculated as follows: number of second booster doses cumulatively
administered divided by the size of the population. The uptake is expressed as
percentage (%). Population denominators are obtained from Eurostat/UN.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.

Please refer to the notes on the data tab for additional information on the data

Data as of 2022-11-17
Disclaimer: the information presented in the ECDC Vaccine Tracker is based on
data reported by EU/EEA countries to the European Surveillance System (TESSy).
EU/EEA countries are requested to report data every two weeks on Tuesdays. The
data in the tracker are refreshed every two weeks on Thursdays at 11h after
validation at ECDC level. Considering this reporting timeframe and the time ECDC
needs to process the data, some discrepancies may be observed between the
figures published by ECDC and the ones presented in official national reports or
web sites. Users are advised to use all data with caution and be aware of their
limitations. Data for the current week are preliminary, as countries may be
uploading only partial data. All data are subject to retrospective corrections;
corrected datasets are released as soon as processing of updated national data
has been completed. Please refer to the "Notes on the data" tab for additional
information.
Total doses distributed to EU/EEA countries
29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland,
Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
KPI Kein Titel


1,352,615,905


KPI Kein Titel


950,861,692


Total doses administered in EU/EEA countries
30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Indicator:
Variable input Kein Titel


Uptake one doseUptake primary courseUptake first boosterUptake second
boosterNumber of first doses administeredNumber of primary courses
administeredNumber of first boosters administeredNumber of second boosters
administered

Country:
SimpleFieldSelect Kein Titel


All EU/EEA
countriesAustriaBelgiumBulgariaCroatiaCyprusCzechiaDenmarkEstoniaFinlandFranceGermanyGreeceHungaryIcelandIrelandItalyLatviaLiechtensteinLithuaniaLuxembourgMaltaNetherlandsNorwayPolandPortugalRomaniaSlovakiaSloveniaSpainSweden

Adults 18+ Adults 60+ Total Population
EU EU/EEA
Karte
CUMULATIVE UPTAKE (%) OF THE PRIMARY COURSE IN THE TOTAL POPULATION IN EU/EEA
COUNTRIES AS OF 2022-11-17

© EuroGeographics © UN–FAO © Turkstat








CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of at least one vaccine dose of any vaccine
product. It is calculated as follows: number of first doses cumulatively
administered divided by the size of the population The uptake is expressed as
percentage (%). Population denominators are obtained from Eurostat/UN.


CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of a complete primary course with any
vaccine product. It is calculated as follows: number of complete primary courses
administered divided by the size of the population. The uptake is expressed as
percentage (%). Primary course is defined according to the authorised schedule
for each vaccine product at EU level. Population denominators are obtained from
Eurostat/UN.


CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the first booster dose. See definition
of first booster below. It is calculated as follows: number of first booster
doses cumulatively administered divided by the size of the population. The
uptake is expressed as percentage (%). Population denominators are obtained from
Eurostat/UN.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.


CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the second booster dose. See definition
of second booster below. It is calculated as follows: number of second booster
doses cumulatively administered divided by the size of the population. The
uptake is expressed as percentage (%). Population denominators are obtained from
Eurostat/UN.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.


NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers only to the
total number of vaccine doses administered as first dose of 2-dose vaccination
course products.


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of complete primary courses administered is cumulative and it refers
to the total number of primary courses administered defined according to the
authorised schedule for each vaccine product at EU level (e.g. second dose of
2-dose vaccination course products, as well as first dose of single dose
vaccination course products such as Janssen).


NUMBER OF BOOSTER DOSES ADMINISTERED

The number of booster doses administered is cumulative and based on the
definition of first and second boosters described above.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to the Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.

VT-Kpi-Text
CUMULATIVE VACCINE UPTAKE (%) IN THE TOTAL POPULATION IN EU/EEA COUNTRIES

One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One
dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0%
One dose
75.3%
Primary course
73.1%
First booster
54.5%
Second booster
11.0%

One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One
dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0%
One dose
75.3%
Primary course
73.1%
First booster
54.5%
Second booster
11.0%

One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One
dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0%
One dose
75.3%
Primary course
73.1%
First booster
54.5%
Second booster
11.0%

One dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0% One
dose 75.3% Primary course 73.1% First booster 54.5% Second booster 11.0%
One dose
75.3%
Primary course
73.1%
First booster
54.5%
Second booster
11.0%



Sammelbox Kein Titel


Leere Sammelbox



Liniendiagramm
CUMULATIVE VACCINE UPTAKE (%) IN THE TOTAL POPULATION IN EU/EEA COUNTRIES AS OF
2022-11-17


BY REPORTING WEEK (DATA FOR THE CURRENT WEEK ARE PRELIMINARY)


At least one doseAt least one dosePrimary coursePrimary courseFirst boosterFirst
boosterSecond boosterSecond booster







CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of at least one vaccine dose of any vaccine
product. It is calculated as follows: number of first doses cumulatively
administered divided by the size of the population The uptake is expressed as
percentage (%). Population denominators are obtained from Eurostat/UN.


CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of a complete primary course with any
vaccine product. It is calculated as follows: number of complete primary courses
administered divided by the size of the population. The uptake is expressed as
percentage (%). Primary course is defined according to the authorised schedule
for each vaccine product at EU level. Population denominators are obtained from
Eurostat/UN.


CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the first booster dose. See definition
of first booster below. It is calculated as follows: number of first booster
doses cumulatively administered divided by the size of the population. The
uptake is expressed as percentage (%). Population denominators are obtained from
Eurostat/UN.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.


CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the second booster dose. See definition
of second booster below. It is calculated as follows: number of second booster
doses cumulatively administered divided by the size of the population. The
uptake is expressed as percentage (%). Population denominators are obtained from
Eurostat/UN.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to the Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.

VT-Kpi-Text
NUMBER OF PEOPLE VACCINATED IN THE TOTAL POPULATION IN EU/EEA COUNTRIES

One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second
booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster
246,780,299 Second booster 49,937,331
One dose
341,123,444
Primary course
331,063,373
First booster
246,780,299
Second booster
49,937,331

One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second
booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster
246,780,299 Second booster 49,937,331
One dose
341,123,444
Primary course
331,063,373
First booster
246,780,299
Second booster
49,937,331

One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second
booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster
246,780,299 Second booster 49,937,331
One dose
341,123,444
Primary course
331,063,373
First booster
246,780,299
Second booster
49,937,331

One dose 341,123,444 Primary course 331,063,373 First booster 246,780,299 Second
booster 49,937,331 One dose 341,123,444 Primary course 331,063,373 First booster
246,780,299 Second booster 49,937,331
One dose
341,123,444
Primary course
331,063,373
First booster
246,780,299
Second booster
49,937,331



Sammelbox Kein Titel


Leere Sammelbox



Balkendiagramm
CUMULATIVE NUMBER OF VACCINE DOSES ADMINISTERED TO THE TOTAL POPULATION IN
EU/EEA COUNTRIES AS OF 2022-11-17


BY REPORTING WEEK (DATA FOR CURRENT WEEK ARE PRELIMINARY)


First dosesFirst dosesPrimary coursesPrimary coursesFirst boostersFirst
boostersSecond boostersSecond boostersUnspecified dosesUnspecified doses






NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers only to the
total number of vaccine doses administered as first dose of 2-dose vaccination
course products.


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of complete primary courses administered is cumulative and it refers
to the total number of primary courses administered defined according to the
authorised schedule for each vaccine product at EU level (e.g. second dose of
2-dose vaccination course products, as well as first dose of single dose
vaccination course products such as Janssen).


NUMBER OF BOOSTER DOSES ADMINISTERED

The number of booster doses administered is cumulative and based on the
following definition of first and second boosters.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to the Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.

Variable input Kein Titel


Weekly dosesCumulative doses


Please refer to the notes on the data tab for additional information on the data

Data as of 2022-11-17
Disclaimer: the information presented in the ECDC Vaccine Tracker is based on
data reported by EU/EEA countries to the European Surveillance System (TESSy).
EU/EEA countries are requested to report data every two weeks on Tuesdays. The
data in the tracker are refreshed every two weeks on Thursdays at 11h after
validation at ECDC level. Considering this reporting timeframe and the time ECDC
needs to process the data, some discrepancies may be observed between the
figures published by ECDC and the ones presented in official national reports or
web sites. Users are advised to use all data with caution and be aware of their
limitations. Data for the current week are preliminary, as countries may be
uploading only partial data. All data are subject to retrospective corrections;
corrected datasets are released as soon as processing of updated national data
has been completed. Please refer to the "Notes on the data" tab for additional
information.
Total doses distributed to EU/EEA countries
29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland,
Portugal, Romania, Slovakia, Slovenia, Spain, Sweden


Total doses administered in EU/EEA countries
30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Indicator:

Target Group:

Country:

EU EU/EEA


CUMULATIVE VACCINE UPTAKE AMONG PEOPLE AGED 60 YEARS AND ABOVE IN EU/EEA
COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to individuals aged 60 years
and above divided by the size of the corresponding population. The uptake is
expressed as percentage (%). Primary course is defined according to the
authorised schedule for each vaccine product at EU level. See definition of
booster/additional doses below. Population denominators for total population and
age-specific population are obtained from Eurostat/UN.


CUMULATIVE VACCINE UPTAKE AMONG HEALTHCARE WORKERS IN EU/EEA COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to healthcare workers (HCW)
divided by the size of the population of HCW as reported by the countries. The
uptake is expressed as percentage (%). Primary course is defined according to
the authorised schedule for each vaccine product at EU level. See definition of
booster/additional doses below.


CUMULATIVE VACCINE UPTAKE AMONG RESIDENTS IN LONG-TERM CARE FACILITIES IN EU/EEA
COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to residents in long-term
care facilities (LTCF) divided by the size of the population of LTCF residents
as reported by the countries. The uptake is expressed as percentage (%). Primary
course is defined according to the authorised schedule for each vaccine product
at EU level. See definition of additional doses below.


NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers to the total
number of vaccine doses administered to adults (18+) or to the total population
only as first dose of 2-dose vaccination course products (i.e. single doses of
Janssen vaccine not included).


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of primary courses administered is cumulative and it refers to the
total number of primary courses administered to adults (18+) or to the total
population. Primary course is defined according to the authorised schedule for
each vaccine product at EU level (e.g. second dose of 2-dose vaccination course
products, as well as first dose of single dose vaccination course products such
as Janssen).


NUMBER OF BOOSTER/ADDITIONAL DOSES ADMINISTERED

The number of booster and additional doses administered is cumulative and it
refers to vaccine doses either administered as a booster dose to individuals who
already received a complete primary course or as an additional dose as extension
of the primary course in certain population groups (e.g. in immunocompromised
individuals).

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to the Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.


CUMULATIVE VACCINE UPTAKE AMONG PEOPLE AGED 60 YEARS AND ABOVE IN EU/EEA
COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to individuals aged 60 years
and above divided by the size of the corresponding population. The uptake is
expressed as percentage (%). Primary course is defined according to the
authorised schedule for each vaccine product at EU level. See definition of
booster/additional doses below. Population denominators for total population and
age-specific population are obtained from Eurostat/UN.


CUMULATIVE VACCINE UPTAKE AMONG HEALTHCARE WORKERS IN EU/EEA COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to healthcare workers (HCW)
divided by the size of the population of HCW as reported by the countries. The
uptake is expressed as percentage (%). Primary course is defined according to
the authorised schedule for each vaccine product at EU level. See definition of
booster/additional doses below.


CUMULATIVE VACCINE UPTAKE AMONG RESIDENTS IN LONG-TERM CARE FACILITIES IN EU/EEA
COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to residents in long-term
care facilities (LTCF) divided by the size of the population of LTCF residents
as reported by the countries. The uptake is expressed as percentage (%). Primary
course is defined according to the authorised schedule for each vaccine product
at EU level. See definition of additional doses below.


NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers to the total
number of vaccine doses administered to adults (18+) or to the total population
only as first dose of 2-dose vaccination course products (i.e. single doses of
Janssen vaccine not included).


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of primary courses administered is cumulative and it refers to the
total number of primary courses administered to adults (18+) or to the total
population. Primary course is defined according to the authorised schedule for
each vaccine product at EU level (e.g. second dose of 2-dose vaccination course
products, as well as first dose of single dose vaccination course products such
as Janssen).


NUMBER OF BOOSTER/ADDITIONAL DOSES ADMINISTERED

The number of booster and additional doses administered is cumulative and it
refers to vaccine doses either administered as a booster dose to individuals who
already received a complete primary course or as an additional dose as extension
of the primary course in certain population groups (e.g. in immunocompromised
individuals).

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to the Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.




CUMULATIVE VACCINE UPTAKE AMONG PEOPLE AGED 60 YEARS AND ABOVE IN EU/EEA
COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to individuals aged 60 years
and above divided by the size of the corresponding population. The uptake is
expressed as percentage (%). Primary course is defined according to the
authorised schedule for each vaccine product at EU level. See definition of
booster/additional doses below. Population denominators for total population and
age-specific population are obtained from Eurostat/UN.


CUMULATIVE VACCINE UPTAKE AMONG HEALTHCARE WORKERS IN EU/EEA COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to healthcare workers (HCW)
divided by the size of the population of HCW as reported by the countries. The
uptake is expressed as percentage (%). Primary course is defined according to
the authorised schedule for each vaccine product at EU level. See definition of
booster/additional doses below.


CUMULATIVE VACCINE UPTAKE AMONG RESIDENTS IN LONG-TERM CARE FACILITIES IN EU/EEA
COUNTRIES

These figures display the cumulative vaccine uptake (presented separately for at
least one dose, a complete primary course and a booster/additional dose) that is
calculated as follows: number of first doses, primary courses or
booster/additional doses, cumulatively administered to residents in long-term
care facilities (LTCF) divided by the size of the population of LTCF residents
as reported by the countries. The uptake is expressed as percentage (%). Primary
course is defined according to the authorised schedule for each vaccine product
at EU level. See definition of additional doses below.


NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers to the total
number of vaccine doses administered to adults (18+) or to the total population
only as first dose of 2-dose vaccination course products (i.e. single doses of
Janssen vaccine not included).


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of primary courses administered is cumulative and it refers to the
total number of primary courses administered to adults (18+) or to the total
population. Primary course is defined according to the authorised schedule for
each vaccine product at EU level (e.g. second dose of 2-dose vaccination course
products, as well as first dose of single dose vaccination course products such
as Janssen).


NUMBER OF BOOSTER/ADDITIONAL DOSES ADMINISTERED

The number of booster and additional doses administered is cumulative and it
refers to vaccine doses either administered as a booster dose to individuals who
already received a complete primary course or as an additional dose as extension
of the primary course in certain population groups (e.g. in immunocompromised
individuals).

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to the Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.

Please refer to the notes on the data tab for additional information on the data

Data as of 2022-11-17
Disclaimer: the information presented in the ECDC Vaccine Tracker is based on
data reported by EU/EEA countries to the European Surveillance System (TESSy).
EU/EEA countries are requested to report data every two weeks on Tuesdays. The
data in the tracker are refreshed every two weeks on Thursdays at 11h after
validation at ECDC level. Considering this reporting timeframe and the time ECDC
needs to process the data, some discrepancies may be observed between the
figures published by ECDC and the ones presented in official national reports or
web sites. Users are advised to use all data with caution and be aware of their
limitations. Data for the current week are preliminary, as countries may be
uploading only partial data. All data are subject to retrospective corrections;
corrected datasets are released as soon as processing of updated national data
has been completed. Please refer to the "Notes on the data" tab for additional
information.
Total doses distributed to EU/EEA countries
29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland,
Portugal, Romania, Slovakia, Slovenia, Spain, Sweden


Total doses administered in EU/EEA countries
30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Indicator:

Country:


EU EU/EEA


CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of at least one vaccine dose of any vaccine
product and is presented by age group. It is calculated as follows: number of
first doses cumulatively administered divided by the size of the population The
uptake is expressed as percentage (%). Population denominators are obtained from
Eurostat/UN. Countries reporting data by age groups in adults may differ from
those reporting data in under 18.


CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of a complete primary course with any
vaccine product and is presented by age group. It is calculated as follows:
number of complete primary courses administered divided by the size of the
population. The uptake is expressed as percentage (%). Primary course is defined
according to the authorised schedule for each vaccine product at EU level.
Population denominators are obtained from Eurostat/UN. Countries reporting data
by age groups in adults may differ from those reporting data in under 18.


CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the first booster dose and is presented
by age group. See definition of first booster below. It is calculated as
follows: number of first booster doses cumulatively administered divided by the
size of the population. The uptake is expressed as percentage (%). Population
denominators are obtained from Eurostat/UN. Countries reporting data by age
groups in adults may differ from those reporting data in under 18.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.


CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the second booster dose and is presented
by age group. See definition of second booster below. It is calculated as
follows: number of second booster doses cumulatively administered divided by the
size of the population. The uptake is expressed as percentage (%). Population
denominators are obtained from Eurostat/UN. Countries reporting data by age
groups in adults may differ from those reporting data in under 18.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.


NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers only to the
total number of vaccine doses administered as first dose of 2-dose vaccination
course products.


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of complete primary courses administered is cumulative and it refers
to the total number of primary courses administered defined according to the
authorised schedule for each vaccine product at EU level (e.g. second dose of
2-dose vaccination course products, as well as first dose of single dose
vaccination course products such as Janssen).


NUMBER OF BOOSTER DOSES ADMINISTERED

The number of booster doses administered is cumulative and based on the
definition of first and second boosters described above.


PROPORTION OF VACCINE DOSES ADMINISTERED BY AGE GROUP

This graph shows the proportion of vaccine doses administered overall (as first,
second, booster or unspecified dose) by age group out of the total number of
doses administered.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.




CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of at least one vaccine dose of any vaccine
product and is presented by age group. It is calculated as follows: number of
first doses cumulatively administered divided by the size of the population The
uptake is expressed as percentage (%). Population denominators are obtained from
Eurostat/UN. Countries reporting data by age groups in adults may differ from
those reporting data in under 18.


CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of a complete primary course with any
vaccine product and is presented by age group. It is calculated as follows:
number of complete primary courses administered divided by the size of the
population. The uptake is expressed as percentage (%). Primary course is defined
according to the authorised schedule for each vaccine product at EU level.
Population denominators are obtained from Eurostat/UN. Countries reporting data
by age groups in adults may differ from those reporting data in under 18.


CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the first booster dose and is presented
by age group. See definition of first booster below. It is calculated as
follows: number of first booster doses cumulatively administered divided by the
size of the population. The uptake is expressed as percentage (%). Population
denominators are obtained from Eurostat/UN. Countries reporting data by age
groups in adults may differ from those reporting data in under 18.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.


CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the second booster dose and is presented
by age group. See definition of second booster below. It is calculated as
follows: number of second booster doses cumulatively administered divided by the
size of the population. The uptake is expressed as percentage (%). Population
denominators are obtained from Eurostat/UN. Countries reporting data by age
groups in adults may differ from those reporting data in under 18.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.


NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers only to the
total number of vaccine doses administered as first dose of 2-dose vaccination
course products.


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of complete primary courses administered is cumulative and it refers
to the total number of primary courses administered defined according to the
authorised schedule for each vaccine product at EU level (e.g. second dose of
2-dose vaccination course products, as well as first dose of single dose
vaccination course products such as Janssen).


NUMBER OF BOOSTER DOSES ADMINISTERED

The number of booster doses administered is cumulative and based on the
definition of first and second boosters described above.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.


CUMULATIVE UPTAKE OF AT LEAST ONE VACCINE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of at least one vaccine dose of any vaccine
product and is presented by age group. It is calculated as follows: number of
first doses cumulatively administered divided by the size of the population The
uptake is expressed as percentage (%). Population denominators are obtained from
Eurostat/UN.


CUMULATIVE UPTAKE OF THE PRIMARY COURSE IN EU/EEA COUNTRIES

This refers to the cumulative uptake of a complete primary course with any
vaccine product and is presented by age group. It is calculated as follows:
number of complete primary courses administered divided by the size of the
population. The uptake is expressed as percentage (%). Primary course is defined
according to the authorised schedule for each vaccine product at EU level.
Population denominators are obtained from Eurostat/UN.


CUMULATIVE UPTAKE OF THE FIRST BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the first booster dose and is presented
by age group. See definition of first booster below. It is calculated as
follows: number of first booster doses cumulatively administered divided by the
size of the population. The uptake is expressed as percentage (%). Population
denominators are obtained from Eurostat/UN.

First booster: for surveillance purpose, this refers to the first additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both first booster doses
administered to immunocompetent persons and additional primary course doses
administered to immunocompromised individuals.


CUMULATIVE UPTAKE OF THE SECOND BOOSTER IN EU/EEA COUNTRIES

This refers to the cumulative uptake of the second booster dose and is presented
by age group. See definition of second booster below. It is calculated as
follows: number of second booster doses cumulatively administered divided by the
size of the population. The uptake is expressed as percentage (%). Population
denominators are obtained from Eurostat/UN.

Second booster: for surveillance purpose, this refers to the second additional
dose of COVID-19 vaccine administered after the standard primary course.
Therefore, the count and uptake estimates may include both second booster doses
administered to immunocompetent persons and second additional doses administered
to immunocompromised individuals after a standard primary course.


NUMBER OF FIRST DOSES ADMINISTERED

The number of first doses administered is cumulative and it refers only to the
total number of vaccine doses administered as first dose of 2-dose vaccination
course products.


NUMBER OF PRIMARY COURSES ADMINISTERED

The number of complete primary courses administered is cumulative and it refers
to the total number of primary courses administered defined according to the
authorised schedule for each vaccine product at EU level (e.g. second dose of
2-dose vaccination course products, as well as first dose of single dose
vaccination course products such as Janssen).


NUMBER OF BOOSTER DOSES ADMINISTERED

The number of booster doses administered is cumulative and based on the
definition of first and second boosters described above.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.

Please refer to the notes on the data tab for additional information on the data

Data as of 2022-11-17
Disclaimer: the information presented in the ECDC Vaccine Tracker is based on
data reported by EU/EEA countries to the European Surveillance System (TESSy).
EU/EEA countries are requested to report data every two weeks on Tuesdays. The
data in the tracker are refreshed every two weeks on Thursdays at 11h after
validation at ECDC level. Considering this reporting timeframe and the time ECDC
needs to process the data, some discrepancies may be observed between the
figures published by ECDC and the ones presented in official national reports or
web sites. Users are advised to use all data with caution and be aware of their
limitations. Data for the current week are preliminary, as countries may be
uploading only partial data. All data are subject to retrospective corrections;
corrected datasets are released as soon as processing of updated national data
has been completed. Please refer to the "Notes on the data" tab for additional
information.
Total doses distributed to EU/EEA countries
29 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Netherlands, Norway, Poland,
Portugal, Romania, Slovakia, Slovenia, Spain, Sweden


Total doses administered in EU/EEA countries
30 Reporting countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Indicator:

Product:


EU EU/EEA


NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES PER
HUNDRED INHABITANTS

These graphs present the total number of vaccine doses distributed by
manufacturers to EU/EEA countries divided by the size of the total population in
each country. Population denominators for the total population are obtained from
Eurostat/UN.


NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY
VACCINE PRODUCT

These graphs present the total number of vaccine doses distributed by
manufacturers to EU/EEA countries by vaccine products.


NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE PRODUCT

These graphs present the total number of vaccine doses administered in EU/EEA
countries to the total population by vaccine products.


BIVALENT VACCINES

Vaccine doses labelled as “Comirnaty bivalent” include doses of both
Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine
doses labelled as “Spikevax bivalent” include doses of both Original/Omicron
BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses
administered for specific bivalent vaccines may be accessed in the Open data
files.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.


NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY
VACCINE PRODUCT

These graphs present the number of vaccine doses distributed by manufacturers to
EU/EEA countries by vaccine products. It may be displayed as cumulative or
weekly.


PROPORTION OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES BY
VACCINE PRODUCT

This figure shows the proportion of vaccines doses distributed by manufacturers
to EU/EEA countries by vaccine product out of the total number of doses supplied
to each country.


NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE PRODUCT

These graphs present the number of vaccine doses administered in EU/EEA
countries by vaccine products. It may be displayed as cumulative or weekly.


BIVALENT VACCINES

Vaccine doses labelled as “Comirnaty bivalent” include doses of both
Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine
doses labelled as “Spikevax bivalent” include doses of both Original/Omicron
BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses
administered for specific bivalent vaccines may be accessed in the Open data
files.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.




TOTAL NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES
BY VACCINE PRODUCT

This graph displays the total number of vaccine doses distributed by
manufacturers to EU/EEA countries by vaccine products.


TOTAL NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE
PRODUCT

This graph displays the total number of vaccine administered in EU/EEA countries
by vaccine products.


BIVALENT VACCINES

Vaccine doses labelled as “Comirnaty bivalent” include doses of both
Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine
doses labelled as “Spikevax bivalent” include doses of both Original/Omicron
BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses
administered for specific bivalent vaccines may be accessed in the Open data
files.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.


TOTAL NUMBER OF VACCINE DOSES DISTRIBUTED BY MANUFACTURERS TO EU/EEA COUNTRIES
BY VACCINE PRODUCT

This graph displays the total number of vaccine doses distributed by
manufacturers to EU/EEA countries by vaccine products.


TOTAL NUMBER OF VACCINE DOSES ADMINISTERED IN EU/EEA COUNTRIES BY VACCINE
PRODUCT

This graph displays the total number of vaccine doses administered in EU/EEA
countries by vaccine products.


BIVALENT VACCINES

Vaccine doses labelled as “Comirnaty bivalent” include doses of both
Original/Omicron BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Vaccine
doses labelled as “Spikevax bivalent” include doses of both Original/Omicron
BA.1 and Original/Omicron BA.4/BA.5 bivalent vaccines. Detailed data on doses
administered for specific bivalent vaccines may be accessed in the Open data
files.

Discrepancies with figures from national reports may be explained by different
data reporting pace and timing of the data presented in the Vaccine Tracker.
Please, refer to Notes on the data tab for additional information on data
reporting and data interpretation.

Please refer to the Notes on the data tab to export the full data set.

Please refer to the notes on the data tab for additional information on the data

Data as of 2022-11-17



GENERAL INFORMATION

The ECDC Vaccine tracker provides an overview of the progress in the rollout of
COVID-19 vaccines in the EU/EEA. It presents detailed information on the number
of vaccine doses distributed by manufacturers to each country for the different
vaccines in use in the EU and the number of doses, primary courses and booster
doses administered to adult individuals (18+), the total population and by age
groups, including below 18 years of age. The total population includes children
for whom the vaccine is not yet indicated or who may not yet be included in
national target groups.

A weekly COVID-19 Country Overview report is also published every week on
Thursdays with updated information on the COVID-19 vaccine rollout in the
EU/EEA.

As a general disclaimer, data should be interpreted with caution, including
comparisons across countries. For their correct interpretation, all possible
factors affecting vaccine deployment in each country should be considered, as
well as data completeness and quality. Data quality is consistently monitored
and discussed with countries. Data may be retrospectively corrected.


COVID-19 VACCINE DATA

The data presented in the Vaccine Tracker are collected through The European
Surveillance System (TESSy). EU/EEA countries report weekly aggregated data on
number of vaccine doses distributed by manufacturers to the country, number of
first, second, booster and unspecified doses administered to adolescents and
children below 18 years of age, adult population (18+) and by age group. Vaccine
doses administered to individuals below 18 years currently mostly include doses
administered to individuals in the age range of 5 to 17 years, and to a lesser
extent doses administered “off label” to children below 5 years with
vulnerabilities. The number of doses distributed by the manufacturers is
calculated based on the number of doses per vial defined for each specific
vaccine in the product information available on the EMA website.

It is not currently possible to differentiate additional doses administered as
extension of the primary course in certain population groups (e.g. in
immunocompromised individuals) and boosters. For surveillance purpose the
following definitions are used for the data presented in the vaccine tracker.
“First booster” refers to the first additional dose of COVID-19 vaccine
administered after the standard primary course. Therefore, the count and uptake
estimates may include both first booster doses administered to immunocompetent
persons and additional primary course doses administered to immunocompromised
individuals. “Second booster” refers to the second additional dose of COVID-19
vaccine administered after the standard primary course. Therefore, the count and
uptake estimates may include both second booster doses administered to
immunocompetent persons and second additional doses administered to
immunocompromised individuals after a standard primary course.

EU/EEA countries are requested to report data every two weeks on Tuesdays. The
data in the vaccine tracker are refreshed every two weeks on Thursdays at 11h
after validation at ECDC level. Considering this reporting timeframe and the
time ECDC needs to process the data, some discrepancies may be observed between
the figures published by ECDC and the ones presented in official national
reports or web sites. At country level different systems to monitor the vaccine
roll out may be in place (see links to national data on the COVID-19 vaccine
rollout in the "Country Profiles" tab).

The cumulative vaccine uptake is expressed as a percentage and calculated as
follows: number of vaccine doses cumulatively administered divided by the size
of the corresponding population. Uptakes are calculated separately for at least
one dose, a complete primary course and booster doses. Primary course is defined
according to the schedule included in the Summary of Product Characteristics for
each vaccine product as authorised by EMA. Population denominators for the total
population, adult population and detailed age groups are obtained from
Eurostat/UN. As of 28 April 2022, new Eurostat/UN population estimates for 2021
are used for the denominators of the total population, adults and detailed age
groups. For some countries, the estimated cumulative vaccine uptake in certain
age groups may exceed 100%. These data should be interpreted with caution and,
when available, explanatory notes are included in the Country Disclaimers below.


DATA COMPLETENESS






COUNTRY DISCLAIMERS




OPEN DATA

 * COVID-19 data collection
 * Open Data COVID-19
 * Open data Vaccine tracker
 * Open data metadata rules

 * Legal notice
 * Copyright
 * Access to TESSy data
 * Personal data protection
 * Language policy
 * Cookie policy

Vaccine tracker v6.1


HELP

HOW TO EXPAND A WIDGET

By clicking on this icon you will be able to expand the widget.

By clicking on this similar icon, the widget will go back to its original size.

--------------------------------------------------------------------------------

HOW TO CREATE SELECTIONS TO A VIEW

By clicking on the different items in this menu, you are able to create
selections in your view. You are able to search or type in the listbox of each
component and select settings. You will see different buttons in the box that
shows up.

You can set different settings to your selection.

To close the box.

To confirm the settings that you would like to see.

--------------------------------------------------------------------------------

HOW TO GO BACK TO A PREVIOUS VIEW

On the top of the page you will find a menu. By clicking on Current selections,
you are able to scroll through a list of previous selections and go back to an
older view.

HOW TO RESET THE SELECTIONS OF YOUR VIEW

On the top of the page you will find a menu. By clicking on Reset selections you
are able to reset the selection.

HOW TO UNDO THE SELECTIONS OF YOUR VIEW

On the top of the page you will find a menu. By clicking on Undo selections you
are able to undo the selection.

HOW TO REDO THE SELECTIONS OF YOUR VIEW

On the top of the page you will find a menu. By clicking on Redo selections you
are able to redo the selection.

--------------------------------------------------------------------------------

HOW TO EXPORT AND VIEW CHART OR DATA

When you hover over a widget, a new button will appear:

By clicking on this button, two options will appear

To export data. You will get the option to export the data, to export it as an
image or to a PDF.

To choose if you want to view a chart or the data. The button will change
according to what you choose

--------------------------------------------------------------------------------

HOW TO ZOOM IN ON A GRAPH

By scrolling with your mouse over a graph, you can zoom in on a few days in a
graph, up till one specific day.

--------------------------------------------------------------------------------

Version 6.1

© European Centre for Disease Prevention and Control (ECDC) 2021


EXPORT DATA

×
Format
CSV XML JSON
Close Export
Loading...


CREATE BOOKMARK

×
Title

Description

Close Create


EXPORT

×
Export data
Export as an image
Image size
Default Custom
Width (pixels)

Height (pixels)

File type
Png Jpeg
Paper size
A3 A4 A5 A6 A7 Custom
Width (mm)

Height (mm)

Orientation
Portrait Landscape
Aspect ratio
Default size Fit to page
Width (pixels)

Height (pixels)

Close Export
Loading...





×

Close

😕 WE MISS YOU...

×
Your session has expired due to inactivity. Please refresh the page to
reconnect.
Refresh